Search

everythinglearnresearchcommunity

for

Search:↓

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Treating underlying metabolic and hormonal issues is key to managing female hair loss.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

NAFLD is common in women with PCOS and may signal metabolic syndrome.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Isotretinoin effectively treats acne with low risk if dosed correctly.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Low prolactin in young women may increase heart and metabolism risks.

The Free Androgen Index is important for diagnosing PCOS due to its strong link with symptoms and risk factors.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

There may be a link between hair loss and heart disease in women, but more research is needed.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

PCOS may increase the risk of high blood pressure and heart issues.

Myo-inositol improves fertility and metabolic health in PCOS with fewer side effects than metformin.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Men with prediabetes have worse sexual health and a higher risk of severe erectile dysfunction.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.